US9694571004 - Common Stock

29.82 **+0.71 (+2.44%) **

Taking everything into account, **WMB** scores **3** out of 10 in our fundamental rating. **WMB** was compared to 375 industry peers in the **Oil, Gas & Consumable Fuels** industry. **WMB** has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, **WMB** is valued expensive at the moment.

ROA (5.3%) VS Industry: 21% outperformed.

0.14

2,236.96

ROE (22%) VS Industry: 36% outperformed.

0.15

22,783.17

Profit Margin (22.5%) VS Industry: 40% outperformed.

0.19

294.23

The low **PEG Ratio**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

The **Price/Earnings Ratio** is **14.00**, which indicates a correct valuation of **WMB**.

With a **Forward Price/Earnings Ratio** of **16.67**, **WMB** is valued correctly.

When comparing the current price to the book value of **WMB**, we can conclude it is valued correctly. It is trading at **3.08** times its book value.

Compared to an average industry **Price/Earning Ratio** of **5.32**, **WMB** is valued more expensive than its industry peers. On top of this 86% of the companies listed in the same industry are cheaper than **WMB**!

Compared to an average industry price book ratio of 1.36, **WMB** is valued more expensive than its industry peers. **83%** of the companies listed in the same industry are valued cheaper.

Compared to an average industry **Enterprise Value to EBITDA** ratio of 3.53, **WMB** is valued more expensive than its industry peers. **87%** of the companies listed in the same industry are valued cheaper.

Price/Earnings (14) VS Industry: 14% outperformed.

150.25

0.01

Price/Book (3.08) VS Industry: 17% outperformed.

4,762.42

0.04

Enterprise Value/ EBITDA (10.32) VS Industry: 13% outperformed.

236.38

0.32

Based on estimates for the next 5 years, **WMB** will show a small growth in **Earnings Per Share**. The EPS will grow by **7.75%** on average per year.

Looking at the last year, **WMB** shows a small growth in **Revenue**. The Revenue has grown by **9.33%** in the last year.

Measured over the past 5 years, **WMB** shows a small growth in **Revenue**. The Revenue has been growing by **6.43%** on average per year.

Based on estimates for the next 5 years, **WMB** will show a small growth in **Revenue**. The Revenue will grow by **2.90%** on average per year.

When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | 16.77% | 22.01% | 51.06% | -1.11% | 0.25% | 4.67% | 7.75% |

Revenue | 6.43% | 10.17% | 9.33% | -1.07% | 1.44% | 3.49% | 2.9% |

The Piotroski-F score of **WMB** is **7.00**. This is a strong score and indicates good health and profitability for **WMB**.

When comparing the Current Ratio of **WMB** to the average industry Current Ratio of **1.18**, **WMB** is less able to pay its short term obligations than its industry peers.

A Quick Ratio of **0.63** indicates that **WMB** may have some problems paying its short term obligations.

When comparing the Quick Ratio of **WMB** to the average industry Current Ratio of **1.00**, **WMB** is less able to pay its short term obligations than its industry peers.

Compared to an average industry Debt to Equity Ratio of **0.24**, **WMB** is requires more financing than its industry peers. **93%** of its industry peers have a better Debt to Equity Ratio.

When comparing the Altman-Z score of **WMB** to the average industry Altman-Z score of **2.05**, **WMB** is less financially healthy than its industry peers.

Debt/Equity (1.93) VS Industry: 7% outperformed.

13.98

0.00

Quick Ratio (0.63) VS Industry: 23% outperformed.

0.00

186.31

Current Ratio (0.69) VS Industry: 22% outperformed.

0.00

186.31

Altman-Z (0.66) VS Industry: 22% outperformed.

-509,914.51

307.34

Compared to an average S&P500 **Dividend Yield** of **2.71**, **WMB** pays a better dividend.

On average, the dividend of **WMB** grows each year by **6.22%**, which is quite nice.

The dividend of **WMB** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

Dividend Yield (6.16%) VS Industry: 53% outperformed.

0.32

63.00

**WILLIAMS COS INC**

NYSE:WMB (6/2/2023, 8:58:08 AM)

**29.82**

**+0.71 (+2.44%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)05-03 2023-05-03/amc

Earnings (Next)07-31 2023-07-31/bmo

Inst Owners85.53%

Inst Owner Change-6.63%

Ins Owners0.37%

Ins Owner Change26.97%

Market Cap36.33B

Analysts74.07

Price Target37.47 (25.65%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 6.16% |

Dividend Growth(5Y)6.22%

DP80.95%

Div Incr Years5

Div Non Decr Years5

Ex-Date06-09 2023-06-09 (0.4475)

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)37.93%

Min EPS beat(2)11.89%

Max EPS beat(2)63.97%

EPS beat(4)3

Avg EPS beat(4)18.95%

Min EPS beat(4)-11.45%

Max EPS beat(4)63.97%

Revenue beat(2)1

Avg Revenue beat(2)6.92%

Min Revenue beat(2)-2.2%

Max Revenue beat(2)16.05%

Revenue beat(4)2

Avg Revenue beat(4)3.82%

Min Revenue beat(4)-2.89%

Max Revenue beat(4)16.05%

PT rev (1m)-0.89%

PT rev (3m)-2.58%

EPS NQ rev (1m)-3.72%

EPS NQ rev (3m)-9.84%

EPS NY rev (1m)0%

EPS NY rev (3m)-1.78%

Revenue NQ rev (1m)5.39%

Revenue NQ rev (3m)-6.63%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-9.91%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 14 | ||

Fwd PE | 16.67 | ||

P/S | 3.15 | ||

P/FCF | 13.05 | ||

P/OCF | 6.83 | ||

P/B | 3.08 | ||

P/tB | 8.81 | ||

EV/EBITDA | 10.32 |

EPS(TTM)2.13

EY7.14%

EPS(NY)1.79

Fwd EY6%

FCF(TTM)2.28

FCFY7.66%

OCF(TTM)4.37

OCFY14.65%

SpS9.46

BVpS9.67

TBVpS3.39

PEG (NY)N/A

PEG (5Y)0.83

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 5.3% | ||

ROE | 22% | ||

ROIC | 6.6% | ||

ROICexc | 6.67% | ||

ROICexgc | 8.06% | ||

OM | 32.45% | ||

PM | 22.5% | ||

GM | 71.96% |

ROA(3y)2.63%

ROA(5y)N/A

ROE(3y)10.95%

ROE(5y)N/A

ROIC(3y)5.08%

ROIC(5y)4.67%

ROICexc(3y)5.16%

ROICexc(5y)4.73%

ROICexgc(3y)6.26%

ROICexgc(5y)5.76%

ROICexcg growth 3Y5.63%

ROICexcg growth 5Y10.04%

ROICexc growth 3Y6.59%

ROICexc growth 5Y11.04%

OM growth 3Y-1.76%

OM growth 5Y4.79%

PM growth 3Y21.79%

PM growth 5Y-7.17%

GM growth 3Y-2.91%

GM growth 5Y-0.82%

F-Score7

Asset Turnover0.24

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 1.93 | ||

Debt/FCF | 8.77 | ||

Debt/EBITDA | 4.24 | ||

Cap/Depr | 125.83% | ||

Profit Quality | 107.33% | ||

Current Ratio | 0.69 | ||

Quick Ratio | 0.63 | ||

Altman-Z | 0.66 |

F-Score7

WACC8.26%

ROIC/WACC0.98

Cap/Depr(3y)85.14%

Cap/Depr(5y)113.99%

Profit Quality(3y)457.79%

Profit Quality(5y)N/A

Growth

EPS 1Y51.06%

EPS 3Y22.01%

EPS 5Y16.77%

EPS growth Q2Q85.37%

EPS Next Y-1.11%

EPS Next 2Y0.25%

EPS Next 3Y4.67%

EPS Next 5Y7.75%

Revenue growth 1Y9.33%

Revenue growth 3Y10.17%

Revenue growth 5Y6.43%

Revenue growth Q2Q22.07%

Revenue Next Year-1.07%

Revenue Next 2Y1.44%

Revenue Next 3Y3.49%

Revenue Next 5Y2.9%

EBIT growth 1Y46.17%

EBIT growth 3Y8.23%

EBIT growth 5Y11.52%

EBIT Next Year81.43%

EBIT Next 3Y25.31%

EBIT Next 5Y16.49%

FCF growth 1Y16.1%

FCF growth 3Y19.06%

FCF growth 5Y32.05%

OCF growth 1Y46.83%

OCF growth 3Y9.8%

OCF growth 5Y9.62%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*